Description of the blood test:

Anti-LKM-1 antibodies are autoantibodies that primarily target an enzyme called Cytochrome P450 2D6, which is found in high concentrations in liver cells (hepatocytes) and kidney tubules. The presence of these antibodies is a hallmark of Autoimmune Hepatitis (AIH) Type 2. This is a condition where the body’s immune system mistakenly attacks the liver, leading to chronic inflammation, scarring (cirrhosis), and potential liver failure if left untreated.

What Does the Test Represent?

• Goal: To detect and measure the concentration of IgG antibodies against liver-kidney microsomes.
• Main Application: Diagnosing Autoimmune Hepatitis Type 2 and differentiating it from viral hepatitis or other liver diseases.
• Method: Indirect Immunofluorescence (IIF) or Enzyme-Linked Immunosorbent Assay (ELISA).

Collection Recommendations (General)

• Timing: Morning collection is preferred.
• Fasting: Fasting for 8–12 hours is recommended; plain water is allowed.
• Material: Venous blood (serum).
• Specific Rules: Inform your doctor about any recent medications or herbal supplements, as some substances can cause “drug-induced” liver injury that mimics autoimmune patterns.

Factors Influencing the Result

• Age and Gender: AIH Type 2 (associated with LKM-1) most commonly affects children and young women. It is often more aggressive than the more common Type 1 AIH.
• Viral Infections: Patients with Chronic Hepatitis C occasionally develop low levels of anti-LKM-1 antibodies. It is crucial to distinguish between a true autoimmune disease and a viral-induced immune reaction.
• Treatment Effect: Antibody levels may decrease during successful immunosuppressive therapy.

When to Take This Test?

• Recommendations: If you have symptoms of liver distress (jaundice/yellowing of the skin, dark urine, persistent fatigue, abdominal pain) and tests for Hepatitis A, B, and C are negative.
• Importance: AIH Type 2 can progress rapidly. Early diagnosis is vital to start steroids or other immune-modulating drugs that can stop the liver damage and prevent the need for a transplant.

Medical Interpretation

• Crucial Note: A positive LKM-1 test is a strong indicator of autoimmune disease, but it must be confirmed by other clinical findings. Only a specialist can “fine-tune” the diagnosis by combining these results with a physical exam and ultrasound data.
• Positive Result: Highly suggestive of Autoimmune Hepatitis Type 2, especially in pediatric or young adult patients.
• Negative Result: Does not rule out autoimmune hepatitis, as Type 1 (detected by ASMA or ANA antibodies) is more common in adults.

Possible Further Investigations

• Liver Function Tests (ALT, AST, Bilirubin): To assess the current level of liver inflammation.
• ASMA (Anti-Smooth Muscle Antibodies): To check for Type 1 Autoimmune Hepatitis.
• Serum Gamma-Globulin/IgG levels: Typically elevated in autoimmune liver disease.
• Liver Biopsy: The definitive test to assess the stage of scarring and the specific pattern of inflammation.
• Consultation with a Hepatologist or Gastroenterologist.

When Does the Next Step Make Sense?

• If the LKM-1 test is positive, the next step is usually a referral to a hepatologist for a possible liver biopsy. This helps determine how much damage has already occurred and guides the intensity of the treatment needed to bring the liver enzymes back to normal.
• All clinical decisions must be made by a healthcare professional based on laboratory, imaging, and histological (biopsy) findings.

👉 If necessary, you can discuss the analysis results with a specialist such as a gastroenterologist (Doctors – TAMC).